Regular Physical Exercise Extends Honeymoon Phase in Type 1 Diabetes Subjects
NCT ID: NCT01789190
Last Updated: 2013-02-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
19 participants
OBSERVATIONAL
2011-01-31
2013-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness of Aerobic Exercise to Mitigate Hyperglycemia After Fasted Resistance Exercise
NCT05203653
Effects of Resistance Exercise on Blood Glucose in Post-menopausal Women With Type 1 Diabetes
NCT05203640
Morning Versus Afternoon Aerobic Exercise in Type 1 Diabetes
NCT06115616
Timing of Resistance Exercise in Type 1 Diabetes
NCT05884814
Effects of Frequency and Duration of Exercise in People With Type 1 Diabetes A Randomized Crossover Study
NCT04089462
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Consultations were initially performed on a weekly basis for the first month, then once a month for the remaining period. In each consultation, patients were asked about diet accomplishment, glycaemia monitoring, insulin injections and exercise performance. All individuals from group A declared to practice regularly intervallic routines, playing team sports (basketball for n=1 and soccer for n=6). Only one individual declared to perform aerobic exercise (long distance running and swimming). At the end of the first year a second blood sample was extracted in the same conditions from each individual to determine the same parameters. Exercise routine accomplishment and follow-up of diet and insulin injections was followed monthly during one more year. At the end of this period, the study was considered finished and the last blood extraction was performed in order to measure the same parameters. Other subjects were excluded because they were not capable to provide data required for study follow up.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group S (sedentary)
Group S included patients that did not perform any physical activity at the moment of onset, continuing with the same habits during the subsequent observational period.
No interventions assigned to this group
Group A (active)
The inclusion criteria for group distribution took in account the principles of the American College of Sports Medicine, considering as active physical activity to practice a moderate-vigorous exercise during 1h, 5 days or more/week. In this context, a sedentary or less active person should be a person that practices any or less than 5h weekly
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* To practice a moderate-vigorous exercise during 1h, 5 days or more/week before onset and continuing practicing for 2 more years for group A (active).
* To practice any or less than 5h weekly before and after onset for group S (sedentary).
* Capable to provide data and blood samples during follow up.
Exclusion Criteria
7 Years
30 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidad Miguel Hernandez de Elche
OTHER
University of Alicante
OTHER
University Hospital A Coruña
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Enrique Roche
PhD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Teresa Martinez-Ramonde, MD
Role: PRINCIPAL_INVESTIGATOR
Endocrinology Departmente, Hospital A Coruna
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Endocrinology Service of the University Hospital Complex of A Coruña (Spain)
A Coruña, A Coruna, Spain
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
PDF of the study
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PS09/01093
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.